NCT01999686 2019-05-28
POSITIF
Dexa Medica Group
Phase 3 Completed
Clinical Trials
9 trialsNCT01733459 2018-07-26
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Dexa Medica Group
Phase 3 Completed
NCT02328404 2016-08-04
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Hayat Pharmaceutical Co. PLC
Phase 3 Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01638988 2015-07-28
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
Clinique Ovo
Phase 3 Withdrawn
NCT01081639 2014-07-31
To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01185782 2013-12-27
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01051024 2012-05-04
Diamel in the Treatment of Polycystic Ovary Syndrome
Catalysis SL
Phase 3 Completed